SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (3917)5/5/1998 10:22:00 AM
From: Dauntless  Read Replies (1) of 7041
 
Hank - aren't you rushing things a little?

Read the article, heard several TV & radio spots about it. At least one radio spot pointed out that it would be YEARS until it was available. They are only doing feasibility studies - this from a Reuters release:

"Pfizer is performing biochemical research on Scherer's Zydis delivery system and may proceed to clinical trials if it can, the paper said."

I've been told it would probably be around 3 years before this type of change would be approved to market.

If anything, this announcement by Pfizer, so soon after their hugely successful release of Viagra is confirmation that Vasomax will have one very strong competitive advantage for the patients for whom it is effective.

Note the very careful wording - I wouldn't want to offend our den mother.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext